About this deal
MeiboPatch ®includes a unique temperature test strip which shows when it is ready for use. 1 This ensures it gets to the right temperature to effectively treat MGD but not too hot that it would burn, ensuring patient safety.
Viso E, Rodríguez-Ares MT, Abelenda D, Oubiña B, Gude F (2012) Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci 53:2601–2606. https://doi.org/10.1167/iovs.11-9228 Gupta PK, Stevens MN, Kashyap N, Priestley Y (2018) Prevalence of meibomian gland atrophy in a pediatric population. Cornea 37:426–430. https://doi.org/10.1097/ico.0000000000001476
Shop by product type
Li B, Fu H, Liu T, Xu M (2020) Comparison of the therapeutic effect of meibomian thermal pulsation LipiFlow ® on obstructive and hyposecretory meibomian gland dysfunction patients. Int Ophthalmol 40:3469–3479. https://doi.org/10.1007/s10792-020-01533-y Korb DR, Greiner JV, Herman J (2001) Comparison of fluorescein break-up time measurement reproducibility using standard fluorescein strips versus the Dry Eye Test (DET) method. Cornea 20:811–815. https://doi.org/10.1097/00003226-200111000-00007 Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 118:615–621. https://doi.org/10.1001/archopht.118.5.615 Villani E, Marelli L, Dellavalle A, Serafino M, Nucci P (2020) Latest evidences on meibomian gland dysfunction diagnosis and management. Ocul Surf 18:871–892. https://doi.org/10.1016/j.jtos.2020.09.001 Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15:438–510. https://doi.org/10.1016/j.jtos.2017.05.011
Naviblef ® Daily Care is recommended to be used as daily maintenance care for patients that have followed blepharitis treatment with Naviblef ® Intensive Care. Naviblef ® Intensive Care may be used to remove severe secretions from the eyelids and eyelashes caused by the following conditions:
Latest Deals
Ten qualified RCTs incorporating 761 patients were analyzed. In the comparison of Lipiflow® treatment and lid hygiene, the subgroup with inconsistent units of randomization and analysis showed that the Lipiflow® treatment brought slight improvement in corneal fluorescein staining (mean difference (MD), − 0.42; 95% CI, − 0.75 to − 0.1), significant improvements in ocular surface disease index (OSDI) score (MD, − 7.4; 95% CI, − 11.06 to − 3.74), Standard Patient Evaluation of Eye Dryness (SPEED) score (MD, − 2.7; 95% CI, − 3.95 to − 1.45), meibomian glands yielding liquid secretion (MGYLS) (MD, 1.3; 95% CI, 0.78 to 1.82), and meibomian glands yielding secretion score (MGYSS) (MD, 4.09; 95% CI, 1.18 to 6.99). Meanwhile, significant improvements were detected in OSDI score, SPEED score, MGYLS, and MGYSS with patients who received Lipiflow® treatment compared with those who received nontreatment. The adverse events were comparable in the two control groups. Conclusions Lemp MA (1995) Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J 21:221–232 Safety is of paramount importance to the pharmaceutical industry. VISUfarma makes every effort to provide helpful, accurate information which is compliant with industry regulations. Naviblef ® Intensive Care may be used to remove severe secretions from the eyelids and eyelashes caused by the following conditions: 1
He JZ, Zhong M (2018) Comparative study between the meibomian pulsation system and the warm compress treatment for MGD. [Chinese]. International Eye Science 18:1324–1328 Finis D, Hayajneh J, König C, Borrelli M, Schrader S, Geerling G (2014) Evaluation of an automated thermodynamic treatment (LipiFlow ®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf 12:146–154. https://doi.org/10.1016/j.jtos.2013.12.001 Tauber J (2020) A 6-Week, Prospective, Randomized, Single-Masked Study of Lifitegrast Ophthalmic Solution 5% Versus Thermal Pulsation Procedure for Treatment of Inflammatory Meibomian Gland Dysfunction. Cornea 39:403–407. https://doi.org/10.1097/ico.0000000000002235Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW (2004) Functional aspects of the tear film lipid layer. Exp Eye Res 78:347–360. https://doi.org/10.1016/j.exer.2003.09.019 Argilés M, Cardona G, Pérez-Cabré E, Rodríguez M (2015) Blink rate and incomplete blinks in six different controlled hard-copy and electronic reading conditions. Invest Ophthalmol Vis Sci 56:6679–6685. https://doi.org/10.1167/iovs.15-16967 MeiboPatch ® comes in the form of a single reusable unit. MeiboPatch ® is made from cotton and grape seeds. It does not contain any perfumes or essential oils. 1